NCT00305955

Brief Summary

The purpose of this study will be to:

  • Determine the amount of visual acuity improvement with treatment of presumed bilateral refractive amblyopia
  • Determine the time course of visual acuity improvement with treatment

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
113

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2004

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2004

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

March 20, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 22, 2006

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2006

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2006

Completed
Last Updated

March 24, 2010

Status Verified

October 1, 2009

Enrollment Period

1.9 years

First QC Date

March 20, 2006

Last Update Submit

March 23, 2010

Conditions

Keywords

amblyopiabilateral amblyopiarefractive error

Outcome Measures

Primary Outcomes (1)

  • Visual acuity of 20/25 or better in both eyes

    52 weeks

Interventions

optimal spectacle correction

Eligibility Criteria

Age3 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Community sample

You may qualify if:

  • Age 3 to \<11 years
  • Able to perform single-surrounded single optotype visual acuity using the ATS HOTV protocol for children 3 to \<7 years old and using the E-ETDRS protocol for children 7 to \<11 years old
  • Monocular visual acuity in each eye, measured using trial frames or phoropter with best correction derived from cycloplegic refraction, meeting the following criteria:
  • Using E-ETDRS testing for patients age 7 to \<11 years: visual acuity 20 to 70 letters (20/40 to 20/400)
  • Using ATS HOTV testing for patients age 3 to \<7 years acuity 20/50 to 20/400
  • Refractive error that meets at least one of the following criteria in each eye:
  • Spherical equivalent \>+4.00 D
  • Astigmatism \>2.00 D
  • Investigator believes that the patient's reduced visual acuity is due to bilateral, refractive amblyopia
  • Investigator not planning to prescribe occlusion, patching or any other amblyopia treatment other than spectacles at this time
  • Cycloplegic refraction and ocular examination within 2 months prior to enrollment

You may not qualify if:

  • Myopia greater than -6.00 D of spherical power in plus cylinder form
  • Ocular cause for decreased acuity in either eye; nystagmus per se will not exclude a patient from the study
  • Refractive correction (spectacles or contact lenses) in past three months and no more than one month of refractive correction ever
  • Prior intraocular or refractive surgery
  • Use of contact lenses during the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University Eye Center

Durham, North Carolina, 27710, United States

Location

Related Publications (1)

  • Wallace DK, Chandler DL, Beck RW, Arnold RW, Bacal DA, Birch EE, Felius J, Frazier M, Holmes JM, Hoover D, Klimek DA, Lorenzana I, Quinn GE, Repka MX, Suh DW, Tamkins S; Pediatric Eye Disease Investigator Group. Treatment of bilateral refractive amblyopia in children three to less than 10 years of age. Am J Ophthalmol. 2007 Oct;144(4):487-96. doi: 10.1016/j.ajo.2007.05.040. Epub 2007 Aug 20.

MeSH Terms

Conditions

AmblyopiaRefractive Errors

Interventions

Eyeglasses

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesVision DisordersSensation DisordersNeurologic ManifestationsEye DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

LensesOptical DevicesEquipment and Supplies

Study Officials

  • David K. Wallace, M.D.

    Duke University Eye Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 20, 2006

First Posted

March 22, 2006

Study Start

August 1, 2004

Primary Completion

July 1, 2006

Study Completion

October 1, 2006

Last Updated

March 24, 2010

Record last verified: 2009-10

Locations